These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 11302413)
61. Antimicrobial cycling: the future or a fad? Hodges BM; White RL Ann Pharmacother; 2001 Oct; 35(10):1224-32. PubMed ID: 11675852 [TBL] [Abstract][Full Text] [Related]
62. [Antibiotic dosing – theory and practice]. Fjeld H; Kjeldstadli K; Steinbakk M Tidsskr Nor Laegeforen; 2020 Sep; 140(13):. PubMed ID: 32998498 [TBL] [Abstract][Full Text] [Related]
63. CROSS-REACTIVITY TO ANTIBIOTICS: PROPOSITIONS FOR SELECTING ALTERNATIVES. Bereznyakov I; Imanova N; Doroshenko O; Lebedynska M Wiad Lek; 2022; 75(7):1752-1756. PubMed ID: 35962693 [TBL] [Abstract][Full Text] [Related]
64. Spread of ceftriaxone non-susceptible pneumococci in South Korea: Long-term care facilities as a potential reservoir. Choi MJ; Noh JY; Cheong HJ; Kim WJ; Kim MJ; Jang YS; Lee SN; Choi EH; Lee HJ; Song JY PLoS One; 2019; 14(1):e0210520. PubMed ID: 30699137 [TBL] [Abstract][Full Text] [Related]
65. Fluoroquinolone and macrolide treatment failure in pneumococcal pneumonia and selection of multidrug-resistant isolates. Pérez-Trallero E; Marimon JM; Iglesias L; Larruskain J Emerg Infect Dis; 2003 Sep; 9(9):1159-62. PubMed ID: 14519256 [TBL] [Abstract][Full Text] [Related]
66. Resistance of Streptococcus pneumoniae to fluoroquinolones--United States, 1995-1999. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2001 Sep; 50(37):800-4. PubMed ID: 11785571 [TBL] [Abstract][Full Text] [Related]
67. Pneumococcal resistance: the treatment challenge. Amsden GW; Amankwa K Ann Pharmacother; 2001 Apr; 35(4):480-8. PubMed ID: 11302413 [TBL] [Abstract][Full Text] [Related]
68. Microbiological and pharmacodynamic considerations in the treatment of infection due to antimicrobial-resistant Streptococcus pneumoniae. Appelbaum PC Clin Infect Dis; 2000 Aug; 31 Suppl 2():S29-34. PubMed ID: 10984325 [TBL] [Abstract][Full Text] [Related]
69. Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Dowell SF; Butler JC; Giebink GS; Jacobs MR; Jernigan D; Musher DM; Rakowsky A; Schwartz B Pediatr Infect Dis J; 1999 Jan; 18(1):1-9. PubMed ID: 9951971 [TBL] [Abstract][Full Text] [Related]
70. Streptococcus pneumoniae: the evolution of antimicrobial resistance to beta-lactams, fluoroquinolones and macrolides. Cornick JE; Bentley SD Microbes Infect; 2012 Jul; 14(7-8):573-83. PubMed ID: 22342898 [TBL] [Abstract][Full Text] [Related]
71. Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States. Doern GV Clin Infect Dis; 2001 Sep; 33 Suppl 3():S187-92. PubMed ID: 11524718 [TBL] [Abstract][Full Text] [Related]
72. [Antibacterial therapy of pneumococcal infections caused by drug resistant microorganisms]. Sidorenko SV Antibiot Khimioter; 2002; 47(7):31-7. PubMed ID: 12516194 [No Abstract] [Full Text] [Related]